Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(One intermediate revision by one other user not shown)
Line 16: Line 16:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
!
 
−
!
 
−
!
 
−
!
 
−
!
 
 
|-
 
|-
 
|CHAPTER 2 (SOFT TISSUE TUMOURS)
 
|CHAPTER 2 (SOFT TISSUE TUMOURS)
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 54: Line 39:
 
|[[STBT5:Lipoma|Lipoma]]
 
|[[STBT5:Lipoma|Lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 70: Line 50:
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 86: Line 61:
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 102: Line 72:
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 123: Line 88:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 132: Line 103:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
+
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 142: Line 113:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 155: Line 124:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Hibernoma|Hibernoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 164: Line 136:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
+
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 174: Line 146:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Hibernoma|Hibernoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 187: Line 157:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 196: Line 169:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
+
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 203: Line 176:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 212: Line 191:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
+
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 222: Line 201:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 235: Line 212:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 244: Line 224:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
+
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 
|Disease
 
|Disease
 
|
 
|
Line 254: Line 234:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 267: Line 245:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Elastofibroma|Elastofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 276: Line 257:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
+
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 
|Disease
 
|Disease
 
|
 
|
Line 283: Line 264:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 292: Line 279:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
+
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 302: Line 289:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 315: Line 300:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 324: Line 312:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
+
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 334: Line 322:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 347: Line 333:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 356: Line 345:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Elastofibroma|Elastofibroma]]
+
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 
|Disease
 
|Disease
 
|
 
|
Line 363: Line 352:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 372: Line 367:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
+
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 382: Line 377:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 395: Line 388:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 404: Line 400:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
+
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 414: Line 410:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 427: Line 421:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 436: Line 433:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
+
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 443: Line 440:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 452: Line 455:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
+
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 459: Line 462:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 468: Line 477:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
+
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 +
|Shashi Shetty and Reba Daniel (resident)
 +
|2/21/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Template added 2/21/2024
−
|
+
|-
 +
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 484: Line 499:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
+
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 494: Line 509:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 499: Line 517:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 512: Line 530:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 523: Line 542:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 532: Line 554:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
+
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 542: Line 564:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 555: Line 575:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 564: Line 587:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
+
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 574: Line 597:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 579: Line 605:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 592: Line 618:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 603: Line 630:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 612: Line 642:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
+
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 652:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 635: Line 663:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 644: Line 675:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
+
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 654: Line 685:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 659: Line 693:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 672: Line 706:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 683: Line 718:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 692: Line 730:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 
|Disease
 
|Disease
−
|Shashi Shetty and Reba Daniel (resident)
 
−
|2/21/2024
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|Template added 2/21/2024
 
 
|
 
|
 
|
 
|
Line 708: Line 741:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 718: Line 751:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 731: Line 762:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 740: Line 774:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
+
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 747: Line 781:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 756: Line 796:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
+
|[[STBT5:Glomus_tumour|Glomus tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 766: Line 806:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 779: Line 817:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 788: Line 829:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
+
|[[STBT5:Leiomyoma|Leiomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 839:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 811: Line 850:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 820: Line 862:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
+
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 827: Line 869:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 836: Line 884:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
+
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 846: Line 894:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 859: Line 905:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 868: Line 917:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
+
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 878: Line 927:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 891: Line 938:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 900: Line 950:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
+
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 907: Line 957:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 916: Line 972:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
+
|[[STBT5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 926: Line 982:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 939: Line 993:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Perineurioma|Perineurioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 948: Line 1,005:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
+
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 958: Line 1,015:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 971: Line 1,026:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 980: Line 1,038:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
+
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 987: Line 1,045:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 996: Line 1,060:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
+
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,006: Line 1,070:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,019: Line 1,081:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,028: Line 1,093:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
+
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,038: Line 1,103:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,051: Line 1,114:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,060: Line 1,126:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
+
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,070: Line 1,136:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,083: Line 1,147:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,092: Line 1,159:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,102: Line 1,169:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,115: Line 1,180:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,124: Line 1,192:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
+
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,134: Line 1,202:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 +
|Disease
 +
|James Solomon, MD, PhD
 +
|2/20/2022
 
|
 
|
 +
|PENDING
 
|
 
|
−
|
+
|Alanna Church
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiosarcoma|Angiosarcoma]]
+
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,150: Line 1,224:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Glomus_tumour|Glomus tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,163: Line 1,235:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,172: Line 1,247:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
+
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,182: Line 1,257:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,195: Line 1,268:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,204: Line 1,280:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyoma|Leiomyoma]]
+
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,214: Line 1,290:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:PEComa|PEComa]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,227: Line 1,301:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,236: Line 1,313:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
+
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,252: Line 1,324:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
+
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
−
|Disease
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|Sadeem Qdaisat
 +
|10/1/23
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Working with Eric McGinnis
 
|
 
|
 +
|2021 template added
 
|-
 
|-
−
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
+
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,278: Line 1,365:
 
|
 
|
 
|
 
|
−
|
+
|-
−
|
+
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Schwannoma|Schwannoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Neurofibroma|Neurofibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Perineurioma|Perineurioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 
−
|Disease
 
−
|James Solomon, MD, PhD
 
−
|2/20/2022
 
−
|
 
−
|PENDING
 
−
|
 
−
|Alanna Church
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:PEComa|PEComa]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|-
 
−
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
 
|Disease
 
|Disease
−
|Sadeem Qdaisat
+
|Ganesh Pandurang, MD
−
|10/1/23
+
|2/28/24
 
|
 
|
 
|PENDING
 
|PENDING
 
|
 
|
−
|Working with Eric McGinnis
+
|Katherine Geiersbach
−
|
 
−
|2021 template added
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,004: Line 1,379:
 
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,019: Line 1,389:
 
|-
 
|-
 
|CHAPTER 4 (BONE TUMOURS)
 
|CHAPTER 4 (BONE TUMOURS)
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 2,050: Line 1,410:
 
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,066: Line 1,421:
 
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,082: Line 1,432:
 
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,098: Line 1,443:
 
|[[STBT5:Enchondroma|Enchondroma]]
 
|[[STBT5:Enchondroma|Enchondroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,114: Line 1,454:
 
|[[STBT5:Osteochondroma|Osteochondroma]]
 
|[[STBT5:Osteochondroma|Osteochondroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,130: Line 1,465:
 
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,146: Line 1,476:
 
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,162: Line 1,487:
 
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,178: Line 1,498:
 
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,194: Line 1,509:
 
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,210: Line 1,520:
 
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,226: Line 1,531:
 
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,242: Line 1,542:
 
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,258: Line 1,553:
 
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,274: Line 1,564:
 
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,290: Line 1,575:
 
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,306: Line 1,586:
 
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,322: Line 1,597:
 
|[[STBT5:Osteoma|Osteoma]]
 
|[[STBT5:Osteoma|Osteoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,338: Line 1,608:
 
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,354: Line 1,619:
 
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,370: Line 1,630:
 
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,386: Line 1,641:
 
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,402: Line 1,652:
 
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,418: Line 1,663:
 
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,434: Line 1,674:
 
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,450: Line 1,685:
 
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,466: Line 1,696:
 
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,482: Line 1,707:
 
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,498: Line 1,718:
 
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,514: Line 1,729:
 
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,530: Line 1,740:
 
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,546: Line 1,751:
 
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,562: Line 1,762:
 
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,578: Line 1,773:
 
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,594: Line 1,784:
 
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,610: Line 1,795:
 
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,626: Line 1,806:
 
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,642: Line 1,817:
 
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,658: Line 1,828:
 
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,674: Line 1,839:
 
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,690: Line 1,850:
 
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,706: Line 1,861:
 
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,722: Line 1,872:
 
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,738: Line 1,883:
 
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,754: Line 1,894:
 
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,770: Line 1,905:
 
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,786: Line 1,916:
 
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,802: Line 1,927:
 
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,818: Line 1,938:
 
|[[STBT5:Bone_metastases|Bone metastases]]
 
|[[STBT5:Bone_metastases|Bone metastases]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,834: Line 1,949:
 
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,850: Line 1,960:
 
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,866: Line 1,971:
 
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,882: Line 1,982:
 
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,898: Line 1,993:
 
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,913: Line 2,003:
 
|-
 
|-
 
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
 
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 2,944: Line 2,024:
 
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,960: Line 2,035:
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,976: Line 2,046:
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,992: Line 2,057:
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 3,008: Line 2,068:
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 3,024: Line 2,079:
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 3,040: Line 2,090:
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|

Latest revision as of 17:56, 28 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease
Elastofibroma Disease
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Solitary fibrous tumour Disease Shashi Shetty and Reba Daniel (resident) 2/21/2024 PENDING Katherine Geiersbach Template added 2/21/2024
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease
Infantile fibrosarcoma Disease
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Giant cell tumour of soft tissue Disease
Synovial haemangioma Disease
Intramuscular angioma Disease
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease
Haemosiderotic fibrolipomatous tumour Disease
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Clear cell sarcoma of soft tissue Disease
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease
CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat 10/1/23 PENDING Working with Eric McGinnis 2021 template added
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease Ganesh Pandurang, MD 2/28/24 PENDING Katherine Geiersbach
Sarcoma with BCOR genetic alterations Disease
CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Osteosarcoma Disease
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease
Osteofibrous dysplasia Disease
Adamantinoma of long bones Disease
Simple bone cyst Disease
Fibrocartilaginous mesenchymoma Disease
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Langerhans cell histiocytosis Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://content.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=14310"